Device for preventing granulation lobular mastitis postoperative scars

By designing a postoperative scar device for preventing granuloma lobular mastitis, which includes a synchronous introduction mechanism and an adjustable introduction area adjustment mechanism, the problems of inaccurate injection injection and inability to adjust the introduction area in the prior art are solved, and efficient and accurate scar prevention and treatment are achieved.

CN119868782APending Publication Date: 2025-04-25ZHONGNAN HOSPITAL OF WUHAN UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202510090159.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-01-21
Publication Date
2025-04-25

AI Technical Summary

Technical Problem

The prior art cannot quantitatively introduce the injection into the dermis layer of the patient during the injection process, and the injection cannot be accurately introduced, which has poor treatment effect. At the same time, it cannot adjust the introduction area according to the size of the scar, which cannot meet the prevention and treatment of scars of different sizes.

Method used

A device for preventing postoperative scarring of granulomatous lobular mastitis is designed, including a carrier shell, an introduction head, a reservoir cylinder and a synchronous introduction mechanism. The synchronous introduction mechanism realizes longitudinal reciprocating movement of the introduction head and quantitative introduction of injection liquid by driving the motor, eccentric wheel, cam and support air cylinder. An adjustable introduction area adjustment mechanism is provided in the introduction head, which can adjust the introduction area according to the scar range.

Benefits of technology

During the postoperative treatment process of the patient, quantitative injection is introduced into the patient's scar skin, which improves the prevention and treatment effect of scars, avoids the waste of injections, realizes precise treatment, and can adjust the introduction area according to the scar size to meet the treatment needs of scars of different sizes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119868782A_ABST
    Figure CN119868782A_ABST
Patent Text Reader

Abstract

The invention discloses a device for preventing granulation lobular mastitis postoperative scars, which comprises a bearing shell and a leading-in head arranged at one end of the bearing shell, and a synchronous leading-in mechanism for accurately controlling the injection leading-in amount in the process of driving the leading-in head to longitudinally reciprocate is also arranged in the bearing shell; the synchronous leading-in mechanism comprises a supporting rod, a driving motor is arranged on one side in the bearing shell, an output shaft of the driving motor is connected with an eccentric wheel, the eccentric wheel is connected with the supporting rod through a connecting rod structure, a cam is arranged on the outer surface of the eccentric wheel, and the cam is further intermittently connected with a pressurizing structure. The pressurizing structure is arranged on one side of the mounting plate; according to the triamcinolone acetonide injection guiding device, a quantitative triamcinolone acetonide injection can be guided into the skin of a surgical scar of a patient, precise treatment is achieved, the guiding area of the guiding head can be adjusted according to the scar range of the patient, and the requirement for prevention and treatment of scars of different sizes is met.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medical devices, and in particular relates to a device for preventing scars after surgery for granulomatous lobular mastitis. Background Art

[0002] The incidence of granulomatous lobular mastitis has increased in recent years. This disease is common in young women, with a long course of disease. If it is not treated properly, the condition is likely to recur, which can cause great harm to the patient's body and mind. At the same time, the disease is prone to misdiagnosis or improper treatment, resulting in prolonged treatment. During the treatment process, when the lump needs to be removed, scars will be left at the site of the removal. Triamcinolone acetonide injection is usually used to prevent and treat scars.

[0003] As disclosed in the invention with authorization announcement number CN114984376B, a hyaluronic acid needle injection structure belongs to the field of medical devices, and includes a negative pressure chamber, a needle, a syringe and a push rod. The needle is installed in the negative pressure chamber, the syringe is connected to the needle, and the push rod is installed on the syringe. The hyaluronic acid needle injection structure also includes a bracket, a driving assembly and a slider. The push rod is slidably installed on the bracket, and the bracket is fixedly connected to the slider. The driving assembly includes a motor, a reducer and a screw. The motor is connected to the reducer, the screw is connected to the reducer, and the slider cooperates with the screw. The motor drives the screw to rotate through the reducer, so that the slider drives the push rod to move relative to the syringe, and the liquid in the syringe is smoothly injected through the needle. Through the above design, the hyaluronic acid needle has high injection accuracy and a stable injection process during injection.

[0004] When the above technical solution is used, it is unable to quantitatively introduce the injection liquid into the patient's dermis during the injection process as the injection action progresses, and the injection liquid cannot be accurately introduced, resulting in poor treatment effect. At the same time, it is unable to adjust the introduction area according to the size of the scar, and cannot meet the needs of small-sized scars. For this reason, we propose a device for preventing postoperative scars after granulomatous lobular mastitis. Summary of the invention

[0005] The purpose of the present invention is to provide a device for preventing postoperative scarring caused by granulomatous lobular mastitis, so as to solve the problem that the prior art proposed in the above background technology cannot quantitatively introduce the injection solution into the patient's dermis during the injection process along with the injection action, cannot accurately introduce the injection solution, and has a poor treatment effect. At the same time, it cannot adjust the introduction area according to the size of the scar, and cannot meet the needs of the introduction of scars of different sizes.

[0006] To achieve the above-mentioned object, the present invention provides the following technical solutions: a device for preventing postoperative scarring of granulomatous lobular mastitis, comprising a bearing shell, an introduction head arranged at one end of the bearing shell, and a liquid storage cylinder arranged at one side of the bearing shell, wherein a synchronous introduction mechanism for accurately controlling the amount of injection liquid introduced during the longitudinal reciprocating movement of the introduction head is also arranged in the bearing shell;

[0007] The synchronous introduction mechanism includes a support rod, which is arranged at one side of the introduction head, and the support rod is movably arranged in the bearing shell, and a driving motor is arranged at one side of the bearing shell, and the output shaft of the driving motor is connected to the eccentric wheel, and the eccentric wheel is connected to the support rod through a connecting rod structure, and a cam is arranged on the outer surface of the eccentric wheel, and the cam and the connecting rod structure are arranged on the same plane opposite to each other, and the cam is also intermittently connected to the pressurizing structure, and the pressurizing structure is arranged at one side of the mounting plate, and the mounting plate is arranged in the bearing shell;

[0008] An adjusting mechanism for adjusting the introduction area is also arranged in the introduction head.

[0009] Preferably, a liquid guide tube is also provided in the support rod, and the liquid guide tube is connected to the liquid storage cylinder through an infusion hose. Through the provision of the infusion hose, the triamcinolone acetonide injection in the liquid storage cylinder can be input into the introduction tube, and the introduction tube can transport the triamcinolone acetonide injection into the introduction head.

[0010] Preferably, one end of the infusion hose passes through an adjustment port, and the adjustment port is arranged on one side of the mounting plate, and can guide the extension and retraction of the infusion hose.

[0011] Preferably, the connecting rod structure includes a connecting rod, one end of which is rotatably arranged on one side of the eccentric wheel, and the other end of the connecting rod is rotatably connected to a connecting frame, and the connecting frame is arranged on one side of the outer surface of the support rod. Through the rotation of the eccentric wheel, the connecting rod can drive the support rod to move back and forth longitudinally, and at the same time drive the introduction head to move back and forth longitudinally, and introduce the triamcinolone acetonide injection into the patient's dermis.

[0012] Preferably, the pressurizing structure includes a supporting gas cylinder, which is arranged on one side surface of the mounting plate, a piston pad body being movably arranged in the supporting gas cylinder, a piston rod being arranged on one side of the piston pad body, a push plate being arranged at one end of the piston rod, the push plate being intermittently connected to a cam, and the piston rod being movably arranged on one side of the mounting plate, so that during the process of introducing triamcinolone acetonide injection by the introduction head, the airflow in the supporting gas cylinder can be quantitatively transported to the liquid storage cylinder, and the triamcinolone acetonide injection can be quantitatively output and introduced.

[0013] Preferably, a return spring is also sleeved on the outer surface of the piston rod, one end of the return spring is connected to the push plate, and the other end of the return spring is connected to the mounting plate. The elastic force of the return spring can automatically drive the piston rod to move back and forth longitudinally.

[0014] Preferably, a slot is provided on the cam, and a pulley is rotatably provided in the slot, and the setting of the pulley facilitates the cam to drive the push plate to move.

[0015] Preferably, an air supply pipe is also provided at one end of the supporting air cylinder, and one end of the air supply pipe is connected to an annular air pipe, and the annular air pipe is arranged in the supporting shell. A plurality of exhaust nozzles are evenly arranged on the annular air pipe, and the exhaust nozzles extend into the liquid storage cylinder, so as to evenly and stably transport the airflow in the supporting air cylinder to the liquid storage cylinder.

[0016] Preferably, the adjustment mechanism includes a central carrier plate, which is arranged in the middle of the installation cavity, and the installation cavity is arranged on one side of the introduction head. A plurality of groups of first introduction needle bodies are equidistantly arranged on the central carrier plate, and one end of the first introduction needle body is movably arranged in the transfer cavity, and the transfer cavity is arranged on the upper side of the introduction head. A first electric push rod is embedded in one side of the installation cavity, and one end of the piston rod of the first electric push rod is connected to the central carrier plate. The first introduction needle body on the central carrier plate can be guided out by extending and retracting the first electric push rod, which is convenient for preventing and treating small-area scars.

[0017] Preferably, a side carrier is also provided outside the central carrier, and a plurality of groups of second introduction needle bodies are evenly arranged on the side carrier, and the second introduction needle bodies are movably arranged in the central cavity. A second electric push rod is also inlaid on the top of the installation cavity, and one end of the piston rod of the second electric push rod is connected to the side carrier, and the second introduction needle body and the bottom of the first introduction needle body are both movably arranged in the pinhole, and the pinhole is arranged at the bottom of the introduction head. By extending and retracting the second electric push rod, the side carrier can be moved and the second introduction needle body can be moved out, and cooperated with the first introduction needle body to carry out preventive treatment of large-area scars.

[0018] Compared with the prior art, the present invention has the following beneficial effects:

[0019] (1) During the postoperative treatment of the patient, the present invention can introduce a quantitative amount of triamcinolone acetonide injection into the patient's surgical scar skin as the introduction head moves back and forth longitudinally, thereby improving the preventive treatment effect on the scar, while not causing a waste of triamcinolone acetonide injection, thereby achieving precise treatment.

[0020] (2) The present application can adjust the introduction area of ​​the introduction head according to the scar range of the patient, thereby greatly improving the treatment effect on the scar and meeting the preventive treatment of scars of different sizes. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 It is a schematic diagram of the overall structure of the present invention;

[0022] Figure 2It is a schematic diagram of a half-section structure of the present invention;

[0023] Figure 3 for Figure 2 A schematic diagram of the enlarged structure at A in the middle;

[0024] Figure 4 It is a partial structural schematic diagram of the synchronous introduction mechanism in the present invention;

[0025] Figure 5 for Figure 4 A schematic diagram of the enlarged structure at B in the middle;

[0026] Figure 6 It is a schematic diagram of a half-section structure of the liquid storage cylinder in the present invention;

[0027] Figure 7 It is a half-section structural schematic diagram of the introduction head in the present invention;

[0028] Figure 8 for Figure 7 Schematic diagram of the enlarged structure at C in the middle;

[0029] Fig. 9 It is a schematic structural diagram of the first introduction needle body in the present invention;

[0030] Fig.10 This is a schematic diagram of the structure of the present invention when treating a small area scar;

[0031] Fig.11 This is a schematic diagram of the structure of the present invention when treating a large area scar;

[0032] In the figure: 1, bearing shell; 2, control panel; 3, adjustment mechanism; 4, introduction head; 5, arc-shaped gripping part; 6, observation port; 7, sealing cover; 8, liquid storage cylinder; 9, battery pack; 101, driving motor; 102, support rod; 103, liquid guide tube; 104, infusion hose; 105, eccentric wheel; 106, connecting frame; 107, connecting rod; 108, cam; 109, mounting plate; 110, piston pad; 111, supporting cylinder; 112, adjustment port; 113, piston rod; 114, gas pipe; 115, Pulley; 116, return spring; 117, push plate; 118, annular air pipe; 119, exhaust nozzle; 120, exhaust check valve; 121, intake check valve; 122, intake pipe; 301, positioning part; 302, shunt pipe; 303, installation cavity; 304, first introduction needle body; 305, center carrier plate; 306, side carrier plate; 307, transfer cavity; 308, first electric push rod; 309, second introduction needle body; 310, second electric push rod; 311, needle hole; 312, diversion channel; 313, overflow hole. DETAILED DESCRIPTION

[0033] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0034] See also Figure 1-Figure 6 The present invention provides a technical solution: a device for preventing postoperative scarring caused by granulomatous lobular mastitis, comprising a carrying shell 1, an introduction head 4 arranged at one end of the carrying shell 1, and a liquid storage cylinder 8 arranged at one side of the carrying shell 1. The liquid storage cylinder 8 can store the prepared triamcinolone acetonide injection. Specifically, a sealing cover 7 corresponding to the liquid storage cylinder 8 is further arranged at one end of the carrying shell 1, which can seal the liquid storage cylinder 8. A synchronous introduction mechanism is also arranged in the carrying shell 1.

[0035] The synchronous introduction mechanism includes a support rod 102, which is arranged on one side of the introduction head 4. The support rod 102 is movably arranged in the bearing shell 1. A driving motor 101 is arranged on one side of the bearing shell 1. The output shaft of the driving motor 101 is connected to the eccentric wheel 105. The eccentric wheel 105 is connected to the support rod 102 through a connecting rod structure. A cam 108 is arranged on the outer surface of the eccentric wheel 105. The cam 108 and the connecting rod structure are arranged on the same plane opposite to each other. The cam 108 is also intermittently connected to the pressurizing structure. The pressurizing structure is arranged on one side of the mounting plate 109. The mounting plate 109 is arranged in the bearing shell 1. Through the connecting rod structure, the support rod 102 can be driven to move back and forth longitudinally, and the introduction head 4 can be driven to move back and forth longitudinally to introduce the triamcinolone acetonide injection.

[0036] See also Figure 3 as well as Figure 4 The connecting rod structure includes a connecting rod 107, one end of which is rotatably arranged on one side of the eccentric wheel 105 through a rotating shaft, and the other end of the connecting rod 107 is rotatably connected to a connecting frame 106 through a rotating shaft. The connecting frame 106 is arranged on one side of the outer surface of the support rod 102. Through the rotation of the eccentric wheel 105, the connecting rod 107 can drive the support rod 102 to move back and forth longitudinally, and at the same time drive the introduction head 4 to move back and forth longitudinally, and introduce the triamcinolone acetonide injection into the patient's dermis.

[0037] See also Figure 4 as well as Figure 6The pressurizing structure includes a supporting gas cylinder 111, which is arranged on the surface of one side of the mounting plate 109. A piston pad 110 is movably arranged in the supporting gas cylinder 111. A piston rod 113 is arranged on one side of the piston pad 110. A push plate 117 is also arranged at one end of the piston rod 113. The push plate 117 is intermittently connected to the cam 108. The piston rod 113 is movably arranged on one side of the mounting plate 109. During the process of introducing the triamcinolone acetonide injection by the introduction head 4, the reciprocating movement of the piston rod 113 drives the piston pad 110 to reciprocate in the supporting gas cylinder 111, so that the airflow in the supporting gas cylinder 111 can be quantitatively transported to the liquid storage cylinder 8, and the triamcinolone acetonide injection can be quantitatively output and introduced.

[0038] A return spring 116 is also sleeved on the outer surface of the piston rod 113, one end of the return spring 116 is connected to the push plate 117, and the other end of the return spring 116 is connected to the mounting plate 109. The elastic force of the return spring 116 can automatically drive the piston rod 113 to move back and forth longitudinally.

[0039] An air supply pipe 114 is also provided at one end of the supporting air cylinder 111, and one end of the air supply pipe 114 is connected to an annular air pipe 118. The annular air pipe 118 is arranged in the supporting shell 1, and a plurality of groups of exhaust nozzles 119 are evenly arranged on the annular air pipe 118. The exhaust nozzles 119 extend into the liquid storage cylinder 8. The supporting air cylinder 111 can evenly and stably transport the airflow in the supporting air cylinder 111 to the liquid storage cylinder 8.

[0040] First, the prepared triamcinolone acetonide injection is introduced into the liquid storage cylinder 8 for storage, and then the sealing cover 7 is tightened, and the area to be introduced is adjusted according to the scar range, and then the device is held, and the introduction head 4 is moved to the patient's scar position, and the eccentric wheel 105 is driven by the driving motor 101 to rotate, and the rotation of the eccentric wheel 105 drives the cam 108 and the connecting rod 107 to rotate, and the connecting rod 107 rotates and drives the support rod 102 to move back and forth longitudinally, and the support rod 102 drives the introduction head 4 to move back and forth longitudinally, and the introduction head 4 moves back and forth longitudinally to introduce the triamcinolone acetonide injection. In this device, when the connecting rod 107 drives the support rod 102 to move downward, the cam 108 fits with the push plate 117 and pushes the push plate 117 to move downward. The plate 117 moves downward, the push rod drives the piston rod 113 to move upward, the piston rod 113 drives the piston pad 110 to move upward in the supporting air cylinder 111, the piston pad 110 moves upward, and the airflow in the supporting air cylinder 111 is delivered to the air delivery pipe 114, the air delivery pipe 114 delivers the airflow to the arc-shaped air pipe, the annular cylinder delivers the airflow evenly to the liquid storage cylinder 8 through multiple groups of exhaust nozzles 119, the air pressure in the liquid storage cylinder 8 is enhanced, and then the triamcinolone acetonide injection in the liquid storage cylinder 8 is delivered to the liquid guide tube 103 through the infusion hose 104, the liquid guide tube 103 delivers the triamcinolone acetonide injection to the introduction head 4, and quantitatively introduces it into the patient's scar skin through the introduction head 4, so as to achieve the effect of preventing scar treatment.

[0041] Specifically, an air intake pipe 122 is also provided on one side of the support air cylinder 111, an air intake check valve 121 is provided on the air intake pipe 122, and an exhaust check valve 120 is provided on the air supply pipe 114. When the piston pad 110 moves back and forth longitudinally, the output air flow will not flow back, and at the same time, the support air cylinder 111 can be automatically replenished with air, thereby ensuring the stability of the air flow output.

[0042] Furthermore, a slot is provided on the cam 108, and a pulley 115 is rotatably provided in the slot. When the eccentric wheel 105 drives the cam 108 to rotate, the cam 108 drives the pulley 115 to rotate, and the pulley 115 contacts the push plate 117, so that the cam 108 drives the push plate 117 to move.

[0043] A liquid guide tube 103 is also provided in the support rod 102, and the liquid guide tube 103 is connected to the liquid storage cylinder 8 through an infusion hose 104. Through the provision of the infusion hose 104, the triamcinolone acetonide injection in the liquid storage cylinder 8 can be input into the introduction tube, and the introduction tube can transport the triamcinolone acetonide injection to the introduction head 4.

[0044] Furthermore, one end of the infusion hose 104 passes through the regulating port 112 , and the regulating port 112 is arranged on one side of the mounting plate 109 , and can guide the extension and retraction of the infusion hose 104 .

[0045] See also Figure 7-Figure 11 The introduction head 4 is also provided with an adjustment mechanism 3 for adjusting the introduction area, the adjustment mechanism 3 includes a central carrier 305, the central carrier 305 is arranged in the middle of the installation cavity 303, the installation cavity 303 is arranged on one side of the introduction head 4, a plurality of first introduction needle bodies 304 are equidistantly arranged on the central carrier 305, one end of the first introduction needle body 304 is movably arranged in the transfer cavity 307, and the transfer cavity 307 is arranged on the upper side of the introduction head 4. Specifically, a positioning portion 301 corresponding to the central carrier 305 is also provided in the transfer cavity 307. When the device is not in use, the first introduction needle body 304 can be stored and the first introduction needle body 304 can be aligned with the positioning portion 301. The positioning part 301 is fitted with the first part 301, thereby sealing the multiple groups of first introduction needle bodies 304 to prevent the overflow of the triamcinolone acetonide injection. A shunt tube 302 is also arranged in the positioning part 301, and the shunt tube 302 is connected with the liquid guide tube 103. When the liquid guide tube 103 transports the triamcinolone acetonide injection, it is transported to the transfer cavity 307 through the shunt tube 302. A first electric push rod 308 is embedded in one side of the installation cavity 303, and one end of the piston rod 113 of the first electric push rod 308 is connected to the central carrier plate 305. Through the extension and retraction of the first electric push rod 308, the first introduction needle body 304 on the central carrier plate 305 can be guided out, which is convenient for preventing and treating small-area scars.

[0046] When the scar area is small, the center carrier 305 can be driven downward by running the first electric push rod 308. At this time, the end of the second introduction needle 309 is in contact with the top of the transfer cavity 307, and the second introduction needle 309 is in a sealed state. The center carrier 305 moves downward to drive multiple groups of first introduction needles 304 to move downward, and multiple groups of introduction needles are moved out of the needle holes 311. When the first introduction needles 304 are completely moved out, the first introduction needles 304 are flush with the bottom of the transfer cavity 307. When the introduction head 4 moves back and forth longitudinally, the triamcinolone acetonide injection in the transfer cavity 307 can be quantitatively transported to the first introduction needle 304, and introduced into the patient's scar skin through the first introduction needle 304.

[0047] See also Figure 7 , Figure 8 as well as Fig.11 A side carrier plate 306 is also arranged outside the central carrier plate 305, and a plurality of second introduction needle bodies 309 are evenly arranged on the side carrier plate 306. The second introduction needle bodies 309 are movably arranged in the central cavity. A second electric push rod 310 is also inlaid on the top of the installation cavity 303. One end of the piston rod 113 of the second electric push rod 310 is connected to the side carrier plate 306. The second introduction needle body 309 and the bottom of the first introduction needle body 304 are both movably arranged in the needle hole 311. The needle hole 311 is arranged at the bottom of the introduction head 4. The side carrier plate 306 can be moved and the second introduction needle body 309 can be moved out by extending and retracting the second electric push rod 310. In cooperation with the first introduction needle body 304, large-area scars can be prevented and treated.

[0048] When the scar area of ​​the patient is large, the second electric push rod 310 is operated, and the second electric push rod 310 drives the side carrier 306 to move downward. The downward movement of the side carrier 306 drives multiple groups of second introduction needles 309 to move downward, and the second introduction needles 309 are moved out of the needle hole 311. When the second introduction needles 309 are completely moved out of the needle hole 311, the second introduction needles 309 fit with the bottom of the transfer cavity 307. When the introduction head 4 moves back and forth longitudinally, the triamcinolone acetonide injection in the transfer cavity 307 can be quantitatively transported to the first introduction needle 304 and the second introduction needle 309, and introduced into the patient's scar skin through the first introduction needle 304 and the second introduction needle 309.

[0049] See also Fig. 9In the present application, the first introduction needle body 304 and the second introduction needle body 309 have the same structure. A diversion channel 312 is set in the first introduction needle body 304 and the second introduction needle body 309. An overflow hole 313 connected to the diversion channel 312 is also set on the first introduction needle body 304 and the second introduction needle body 309. During the introduction of triamcinolone acetonide injection, the triamcinolone acetonide injection in the transfer cavity 307 can be transported through the diversion channel 312, and then introduced into the patient's scar skin through the overflow hole 313 at the end, thereby realizing the accurate and precise introduction of triamcinolone acetonide injection.

[0050] A control panel 2 for controlling the operation of the first electric push rod 308 , the second electric push rod 310 and the driving motor 101 is also disposed on the bearing housing 1 .

[0051] An observation port 6 is also provided on the bearing shell 1 , through which the liquid level information of the triamcinolone acetonide injection in the liquid storage cylinder 8 can be observed.

[0052] At the same time, an arc-shaped gripping portion 5 is also provided on the bearing shell 1 for the operator to hold, thereby improving the holding comfort.

[0053] A battery pack 9 is also disposed in the bearing shell 1 . The battery pack 9 can be charged and used cyclically. The battery pack 9 provides electric energy for the operation of the first electric push rod 308 , the second electric push rod 310 and the driving motor 101 .

[0054] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A device for preventing postoperative scarring caused by granulomatous lobular mastitis, comprising a load-bearing shell (1), an introduction head (4) arranged at one end of the load-bearing shell (1), and a liquid storage cylinder (8) arranged at one side of the load-bearing shell (1), characterized in that: The bearing shell (1) is also provided with a synchronous introduction mechanism for accurately controlling the amount of injection liquid introduced during the longitudinal reciprocating movement of the introduction head (4); The synchronous introduction mechanism comprises a support rod (102), the support rod (102) being arranged on one side of the introduction head (4), the support rod (102) being movably arranged in the bearing shell (1), a driving motor (101) being arranged on one side in the bearing shell (1), the output shaft of the driving motor (101) being connected to an eccentric wheel (105), the eccentric wheel (105) being connected to the support rod (102) via a connecting rod structure, a cam (108) being arranged on the outer surface of the eccentric wheel (105), the cam (108) and the connecting rod structure being arranged opposite to each other on the same plane, the cam (108) being also intermittently connected to a pressurizing structure, the pressurizing structure being arranged on one side of a mounting plate (109), the mounting plate (109) being arranged in the bearing shell (1); An adjusting mechanism (3) capable of adjusting the introduction area is also arranged in the introduction head (4).

2. The device for preventing scars after granulomatous lobular mastitis surgery according to claim 1, characterized in that: A liquid guide tube (103) is also arranged inside the support rod (102), and the liquid guide tube (103) is connected to the liquid storage cylinder (8) via a liquid infusion hose (104).

3. The device for preventing scars after granulomatous lobular mastitis surgery according to claim 2, characterized in that: One end of the infusion hose (104) passes through the regulating port (112), and the regulating port (112) is arranged on one side of the mounting plate (109).

4. The device for preventing scars after granulomatous lobular mastitis surgery according to claim 1, characterized in that: The connecting rod structure comprises a connecting rod (107), one end of which is rotatably arranged on one side of the eccentric wheel (105), and the other end of which is rotatably connected to a connecting frame (106), and the connecting frame (106) is arranged on one side of the outer surface of the support rod (102).

5. The device for preventing scars after granulomatous lobular mastitis surgery according to claim 1, characterized in that: The pressurizing structure comprises a supporting gas cylinder (111), wherein the supporting gas cylinder (111) is arranged on a surface of one side of a mounting plate (109), wherein a piston pad body (110) is movably arranged in the supporting gas cylinder (111), wherein a piston rod (113) is arranged on one side of the piston pad body (110), wherein a push plate (117) is also arranged at one end of the piston rod (113), wherein the push plate (117) is intermittently connected to a cam (108), and wherein the piston rod (113) is movably arranged on one side of the mounting plate (109).

6. The device for preventing scars after granulomatous lobular mastitis surgery according to claim 5, characterized in that: A return spring (116) is also sleeved on the outer surface of the piston rod (113), one end of the return spring (116) is connected to the push plate (117), and the other end of the return spring (116) is connected to the mounting plate (109).

7. A device for preventing scars after granulomatous lobular mastitis surgery according to claim 5 or 6, characterized in that: The cam (108) is provided with a slot, and a pulley (115) is rotatably arranged in the slot.

8. The device for preventing scars after granulomatous lobular mastitis surgery according to claim 5, characterized in that: An air delivery pipe (114) is also provided at one end of the supporting air cylinder (111), one end of the air delivery pipe (114) is connected to an annular air pipe (118), the annular air pipe (118) is arranged in the bearing shell (1), a plurality of groups of exhaust nozzles (119) are evenly arranged on the annular air pipe (118), and the exhaust nozzles (119) extend into the liquid storage cylinder (8).

9. The device for preventing scars after granulomatous lobular mastitis surgery according to claim 1, characterized in that: The adjustment mechanism (3) comprises a central carrier (305), wherein the central carrier (305) is arranged in the middle of the installation cavity (303), wherein the installation cavity (303) is arranged on one side of the introduction head (4), wherein a plurality of groups of first introduction needle bodies (304) are arranged at equal intervals on the central carrier (305), wherein one end of the first introduction needle body (304) is movably arranged in a transfer cavity (307), wherein the transfer cavity (307) is arranged on the upper side of the introduction head (4), and a first electric push rod (308) is embedded in one side of the installation cavity (303), wherein one end of the piston rod (113) of the first electric push rod (308) is connected to the central carrier (305).

10. The device for preventing scars after granulomatous lobular mastitis surgery according to claim 9, characterized in that: A side carrier (306) is also arranged outside the central carrier (305), and a plurality of groups of second introduction needle bodies (309) are evenly arranged on the side carrier (306). The second introduction needle bodies (309) are movably arranged in the central cavity. A second electric push rod (310) is also embedded in the top of the installation cavity (303), and one end of the piston rod (113) of the second electric push rod (310) is connected to the side carrier (306). The bottoms of the second introduction needle body (309) and the first introduction needle body (304) are both movably arranged in the needle hole (311), and the needle hole (311) is arranged at the bottom of the introduction head (4).

Citation Information

Patent Citations

  • A water-light injection structure

    CN114984376B